[1]
|
Kavanaugh, B.P. and McCowen, K.C. (2010) Glycemic Control in the ICU. The New England Journal of Medicine, 363, 2540-2546. https://doi.org/10.1056/NEJMcp1001115
|
[2]
|
Moghissi, E.S., Korytkowski, M.T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I.B., Inzucchi, S.E., Ismail-Beigi, F., Kirkman, M.S. and Umpierrez, G.E. (2009) American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care, 32, 1119-1131. https://doi.org/10.2337/dc09-9029
|
[3]
|
Kelly, J.L. (2014) Continuous Insulin Infusion: When, Where, and How? Diabetes Spectrum, 27, 218-223. https://doi.org/10.2337/diaspect.27.3.218
|
[4]
|
Dombrowski, N.C. and Karounos, D.G. (2013) Pathophysiology and Management Strategies for Hyperglycemia for Patients with Acute Illness during and Following a Hospital Stay. Metabolism, 62, 326-336. https://doi.org/10.1016/j.metabol.2012.07.020
|
[5]
|
Dziedzic, T., Slowik, A., Pera, J. and Szczudlik, A. (2009) Association between Hyperglycemia, Heart Failure, and Mortality in Stroke Patients. European Journal of Neurology, 16, 251-256. https://doi.org/10.1111/j.1468-1331.2008.02400.x
|
[6]
|
Moghissi, E.S., Korytkowski, M.T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I.B., Inzucchi, S.E., Ismail-Beigi, F., Kirkman, M.S. and Umpierrez, G.E. (2009) American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Endocrine Practice, 15, 353-369. https://doi.org/10.4158/EP09102.RA
|
[7]
|
Falciglia, M., Freyburg, R.W., Almenoff, P.L., D’Alessio, D.A. and Render, M.L. (2009) Hyperglycemia-Related Mortality in Critically Ill Patients Varies with Admission Diagnosis. Critical Care Medicine, 37, 3001-3009. https://doi.org/10.1097/CCM.0b013e3181b083f7
|
[8]
|
Laird, A.M., Miller, P.R., Kilgo, P.D., Meredith, J.W. and Change, M.C. (2004) Relationship of Early Hyperglycemia to Mortality in Trauma Patients. The Journal of Trauma, 56, 1058-1062. https://doi.org/10.1097/01.TA.0000123267.39011.9F
|
[9]
|
Krinsley, J.S. (2003) Association between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients. Mayo Clinic Proceedings, 78, 1471-1478. https://doi.org/10.4065/78.12.1471
|
[10]
|
Marfella, R., Siniscalchi, M., Esposito, K., Sellitto, A., De Fanis, U., Romano, C., Portoghese, M., Siciliano, S., Nappo, F., Sasso, F.C. and Mininni, N. (2003) Effects of Stress Hyperglycemia on Acute Myocardial Infarction: Role of Inflammatory Immune Process in Functional Cardiac Outcome. Diabetes Care, 26, 3129-3135. https://doi.org/10.2337/diacare.26.11.3129
|
[11]
|
Dungan, K.M., Braithwaite, S.S. and Preiser, J.C. (2009) Stress Hyperglycemia. The Lancet, 373, 1798-1807. https://doi.org/10.1016/S0140-6736(09)60553-5
|
[12]
|
Saand, A.R., Flores, M., Kewan, T., Alqaisi, S., Alwakeel, M., Griffiths, L., Wang, X., Han, X., Burton, R., Al-Jaghbeer, M.J. and Fadel, F.A. (2021) Does Inpatient Hyperglycemia Predict Worse Outcomes in COVID-19 Intensive Care Unit Patients? Journal of Diabetes, 13, 253-260. https://doi.org/10.1111/1753-0407.13137
|
[13]
|
Godinjak, A., Iglica, A., Burekovic, A., Jusufovic, S., Ajanovic, A., Tancica, I. and Kukuljac, A. (2015) Hyperglycemia in Critically Ill Patients: Management and Prognosis. Medical Archives, 69, 157-160. https://doi.org/10.5455/medarh.2015.69.157-160
|
[14]
|
Handelsman, Y., Bloomgarden, Z.T., Grunberger, G., Umpierrez, G., Zimmerman, R.S., Bailey, T.S., Blonde, L., Bray, G.A., Cohen, A.J., Dagogo-Jack, S., Davidson, J.A., Einhorn, D., Ganda, O.P., Garber, A.J., Garvey, W.T., Henry, R.R., Hirsch, I.B., Horton, E.S., Hurley, D.L., Jellinger, P.S., Jovanovič, L., Lebovitz, H.E., LeRoith, D., Levy, P., McGill, J.B., Mechanick, J.I., Mestman, J.H., Moghissi, E.S., Orzeck, E.A., Pessah-Pollack, R., Rosenblit, P.D., Vinik, A.I., Wyne, K. and Zangeneh, F. (2015) American Association of Clinical Endocrinologists and American College of Endocrinology-Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan—2015. Endocrine Practice, 21, 1-87. https://doi.org/10.4158/EP15672.GLSUPPL
|
[15]
|
American Diabetes Association (2021) 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44, S211-S220. https://doi.org/10.2337/dc21-S015
|
[16]
|
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S.S., Deutschman, C., Freire, A.X., Geehan, D., Kohl, B., Nasraway, S.A., Rigby, M., Sands, K., Schallom, L., Taylor, B., Umpierrez, G., Mazuski, J. and Schunemann, H. (2012) Guidelines for the Use of an Insulin Infusion for the Management of Hyperglycemia in Critically Ill Patients. Critical Care Medicine, 40, 3251-3276. https://doi.org/10.1097/CCM.0b013e3182653269
|
[17]
|
Roberts, G.W., Aguilar-Loza, N., Esterman, A., Burt, M.G. and Stranks, S.N. (2012) Basal-Bolus Insulin versus Sliding-Scale Insulin for Inpatient Glycaemic Control: A Clinical Practice Comparison. The Medical Journal of Australia, 194, 266-269. https://doi.org/10.5694/mja11.10853
|
[18]
|
Perez, A., Ramos, A. and Carreras, G. (2020) Insulin Therapy in Hospitalized Patients. American Journal of Therapeutics, 27, e71-e78. https://doi.org/10.1097/MJT.0000000000001078
|
[19]
|
Duggan, E.W., Carlson, K. and Umpierrez, G.E. (2017) Perioperative Hyperglycemia Management: An Update. Anesthesiology, 126, 547-560. https://doi.org/10.1097/ALN.0000000000001515
|
[20]
|
Bilotta, F., Badenas, R., Lolli, S., Belda, F.J., Einav, S. and Rosa, G. (2015) Insulin Infusion Therapy in Critical Care Patients: Regular Insulin vs. Short-Acting Insulin. A Prospective, Crossover, Randomized, Multicenter Blind Study. Journal of Critical Care, 30, 437.e1-6. https://doi.org/10.1016/j.jcrc.2014.10.019
|
[21]
|
Masood, M.Q., Batool, S., Banu, S. and Hussain, E. (2021) Efficacy and Safety of a New Insulin Infusion Protocol Adapted for the Target Glycemic Range of 140-180 mg/dl in Adult Critical Care Units: A Tertiary Care Centre Experience. International Journal of Diabetes in Developing Countries, 41, 469-475. https://doi.org/10.1007/s13410-020-00915-3
|
[22]
|
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P. and Bouillon, R. (2001) Intensive Insulin Therapy in Critically Ill Patients. The New England Journal of Medicine, 345, 1359-1367. https://doi.org/10.1056/NEJMoa011300
|
[23]
|
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., Van Wijngaerden, E., Bobbaers, H. and Bouillon, R. (2006) Intensive Insulin Therapy in the Medical ICU. The New England Journal of Medicine, 354, 449-461. https://doi.org/10.1056/NEJMoa052521
|
[24]
|
American Diabetes Association (2008) Standards of Medical Care in Diabetes—2008. Diabetes Care, 31, S12-S54. https://doi.org/10.2337/dc08-S012
|
[25]
|
The NICE-SUGAR Study Investigators (2009) Intensive versus Conventional Glucose Control in Critically Ill Patients. The New England Journal of Medicine, 360, 1283-1297. https://doi.org/10.1056/NEJMoa0810625
|
[26]
|
Griesdale, D.E.G., de Souza, R.J., van Dam, R.M., Daren, K., Heyland, D.K., Cook, D.J., Malhotra, A., Dhaliwal, R., Henderson, W.R., Chittock, D.R., Finfer, S. and Talmor, D. (2009) Intensive Insulin Therapy and Mortality among Critically Ill Patients: A Meta-Analysis Including NICE-SUGAR Study Data. The Canadian Medical Association Journal, 180, 821-827. https://doi.org/10.1503/cmaj.090206
|
[27]
|
The NICE-SUGAR Study Investigators (2012) Hypoglycemia and Risk of Death in Critically Ill Patients. The New England Journal of Medicine, 367, 1108-1118. https://doi.org/10.1056/NEJMoa1204942
|
[28]
|
The NICE-SUGAR Study Investigators (2015) Intensive versus Conventional Glucose Control in Critically Ill Patients with Traumatic Brain Injury: Long-Term Follow-Up of a Subgroup of Patients from the NICE-SUGAR Study. Intensive Care Medicine, 41, 1037-1047. https://doi.org/10.1007/s00134-015-3757-6
|
[29]
|
Krinsley, J.S. (2015) Glycemic Control in the Critically Ill: What Have We Learned since NICE-SUGAR? Hospital Practice, 43, 191-197. https://doi.org/10.1080/21548331.2015.1066227
|
[30]
|
Galindo, R.J., Umpierrez, G.E., Rushakoff, R.J., Basu, A., Lohnes, S., Nichols, J.H., Spanakis, E.K., Espinoza, J., Palermo, N.E., Awadjie, D.G., Bak, L., Buckingham, B., Cook, C.B., Freckmann, G., Heinemann, L., Hovorka, R., Mathioudakis, N., Newman, T., O’Neal, D.N., Rickert, M., Sacks, D.B., Seley, J.J., Wallia, A., Shang, T., Zhang, J.Y., Han, J. and Klonoff, D.C. (2020) Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. Journal of Diabetes Science and Technology, 14, 1035-1064. https://doi.org/10.1177/1932296820954163
|
[31]
|
Lu, M., Zuo, Y., Guo, J., Wen, X. and Kang, Y. (2018) Continuous Glucose Monitoring System Can Improve the Quality of Glucose Control and Glucose Variability Compared with Point-of-Care Measurement in Critically Ill Patients: A Randomized Controlled Trial. Medicine (Baltimore), 97, e12138. https://doi.org/10.1097/MD.0000000000012138
|
[32]
|
Boom, D.T., Sechterberger, M.K., Rijkenberg, S., Kreder, S., Bosman, R.J., Wester, J.P., van Stijn, I., DeVries, J.H. and van der Voort, P.H. (2014) Insulin Treatment Guided by Subcutaneous Continuous Glucose Monitoring Compared to Frequent Point-of-Care Measurement in Critically Ill Patients: A Randomized Controlled Trial. Critical Care, 18, Article No. 453. https://doi.org/10.1186/s13054-014-0453-9
|
[33]
|
Tanenberg, R.J., Hardee, S., Rothermel, C. and Drake, A.J. (2017) Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: A 7-Year Retrospective Observational Study at a Tertiary Care Teaching Hospital. Endocrine Practice, 23, 331-341. https://doi.org/10.4158/EP161402.OR
|
[34]
|
Dubois, J., Van Herpe, T., van Hooijdonk, R.T., Wouters, R., Coart, D., Wouters, P., Van Assche, A., Veraghtert, G., De Moor, B., Wauters, J., Wilmer, A., Schultz, M.J., Van den Berghe, G. and Mesotten, D. (2017) Software-Guided versus Nurse-Directed Blood Glucose Control in Critically Ill Patients: The LOGIC-2 Multicenter Randomized Controlled Clinical Trial. Critical Care, 21, Article No. 212. https://doi.org/10.1186/s13054-017-1799-6
|
[35]
|
Hashemi, N., Valk, T., Houlind, K. and Ejskjaer, N. (2019) Insulin-Based Infusion System: Advancing the Development. Journal of Diabetes Science and Technology, 13, 941-948. https://doi.org/10.1177/1932296819832876
|
[36]
|
Umpierrez, G.E., Hellman, R., Korytkowski, M.T., Kosiborod, M., Maynard, G.A., Montori, V.M., Seley, J.J., Van den Berghe, G. and Endocrine Society (2012) Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 97, 16-38. https://doi.org/10.1210/jc.2011-2098
|
[37]
|
Avanzini, F., Marelli, G., Donzelli, W., Busi, G., Carbone, S., Bellato, L., Colombo, E.L., Foschi, R., Riva, E., Roncaglioni, M.C., De Martini, M. and Desio Diabetes Diagram Study Group (2011) Transition from Intravenous to Subcutaneous Insulin. Diabetes Care, 34, 1445-1450. https://doi.org/10.2337/dc10-2023
|
[38]
|
Doolin, M.K., Walroth, T.A., Harris, S.A., Whitten, J.A. and Fritschle-Hilliard, A.C. (2016) Transition from Intravenous to Subcutaneous Insulin in Critically Ill Adults. Journal of Diabetes Science and Technology, 10, 932-938. https://doi.org/10.1177/1932296816629985
|